Phase IIa proof-of-concept trial of VGX 100 in patients with breast cancer-related lymphoedema.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
Price : $35 *
At a glance
- Drugs VGX 100 (Primary)
- Indications Breast cancer; Lymphoedema
- Focus Therapeutic Use
- 24 Dec 2013 This trial is expected to start in quarter 1, 2014, according to a Circadian Technologies media release.
- 24 Dec 2013 New trial record